Search Results - "Middleton, Rachel J."

Estimating renal function in old people: an in-depth review by Raman, Maharajan, Middleton, Rachel J., Kalra, Philip A., Green, Darren

“…Estimates of glomerular filtration rate (eGFR) should provide accurate measure of an individual’s kidney function because important clinical decisions such as…”
Get full text

Serum Phosphate and Mortality in Patients with Chronic Kidney Disease by Eddington, Helen, Hoefield, Richard, Sinha, Smeeta, Chrysochou, Constantina, Lane, Beverley, Foley, Robert N, Hegarty, Janet, New, John, O'Donoghue, Donal J, Middleton, Rachel J, Kalra, Philip A

“…Higher phosphate is associated with mortality in dialysis patients but few prospective studies assess this in nondialysis patients managed in an outpatient…”
Get full text

Outcomes in dialysis versus conservative care for older patients: A prospective cohort analysis of stage 5 Chronic Kidney Disease by Raman, Maharajan, Middleton, Rachel J, Kalra, Philip A, Green, Darren

“…The benefits of dialysis in older people with ESKD are not clear. We prospectively evaluated whether dialysis has survival advantage compared to conservative…”
Get full text

Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort by Pullerits, Kairi, Garland, Shona, Rengarajan, Sharmilee, Guiver, Malcolm, Chinnadurai, Rajkumar, Middleton, Rachel J, Chukwu, Chukwuma A, Kalra, Philip A

“…Opportunistic infections remain a significant cause of morbidity and mortality after kidney transplantation. This retrospective cohort study aimed to assess…”
Get full text

Factors Associated With Kidney Disease Progression and Mortality in a Referred CKD Population by Hoefield, Richard A., MRCP, Kalra, Philip A., MD, Baker, Patricia, PhD, Lane, Beverley, MSc, New, John P., FRCP, O'Donoghue, Donal J., FRCP, Foley, Robert N., MD, Middleton, Rachel J., FRCP

“…Background Knowing how kidney disease progresses is important for decision making in patients with chronic kidney disease (CKD) and for designing clinical…”
Get full text

Comparing the impact of older age on outcome in chronic kidney disease of different etiologies: a prospective cohort study by Raman, Maharajan, Green, Darren, Middleton, Rachel J., Kalra, Philip A.

“…Background In older patients with chronic kidney disease (CKD), the risk of progression to end stage renal disease and cardiovascular death both differ…”
Get full text

The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD by Alderson, Helen V, Ritchie, James P, Pagano, Sabrina, Middleton, Rachel J, Pruijm, Menno, Vuilleumier, Nicolas, Kalra, Philip A

“…Elevated levels of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin are associated with negative outcomes in CKD. Our study…”
Get full text

Impact of Shielding and First Dose of COVID-19 Vaccination in Kidney Transplant Recipients by Middleton, Rachel J, Gorton, Julie, O'Riordan, Edmond, Knight, Sean, Kalra, Philip A, Poulikakos, Dimitrios

Get more information

The use of eGFR and ACR to predict decline in renal function in people with diabetes by HOEFIELD, Richard A, KALRA, Philip A, BAKER, Patricia G, SOUSA, Ines, DIGGLE, Peter J, GIBSON, Martin J, O'DONOGHUE, Donal J, MIDDLETON, Rachel J, NEW, John P

“…There have been few attempts to estimate progression of kidney disease in people with diabetes in a single large population with predictive modelling. The aim…”
Get full text

Left ventricular hypertrophy in the renal patient by MIDDLETON, Rachel J, PARFREY, Patrick S, FOLEY, Robert N

Get full text

Effect of a Quality Improvement Program to Improve Guideline Adherence and Attainment of Clinical Standards in Dialysis Care: Report of Outcomes in Year 1 by Youssouf, Sajeda, Nache, Azri, Wijesekara, Chandrakumaran, Middleton, Rachel J, Lewis, David, Shurrab, Aladdin E, O'Riordan, Edmond, Lappin, Lesley P, O'Donoghue, Donal, Kalra, Philip A, Hegarty, Janet

“…Best practice in dialysis is synthesised in clear international guidelines. However, a large gap remains between the international guidelines and the actual…”
Get more information

The unrecognized prevalence of chronic kidney disease in diabetes by Middleton, Rachel J., Foley, Robert N., Hegarty, Janet, Cheung, Ching M., McElduff, Patrick, Gibson, J. Martin, Kalra, Philip A., O'Donoghue, Donal J., New, John P.

“…Background. Diabetes mellitus and chronic kidney disease (CKD) are common and exhibit synergistic associations with premature mortality. Current diabetes…”
Get full text

OLDER PEOPLE WITH CHRONIC KIDNEY DISEASE: DEFINITION, AND INFLUENCE OF BIOMARKERS AND MEDICATIONS UPON CARDIOVASCULAR AND RENAL OUTCOMES by Raman, Maharajan, Green, Darren, Middleton, Rachel J., Kalra, Philip A.

“…SUMMARY Background Chronic kidney disease (CKD) is a global problem. With an ageing population the burden on the health services has increased due to the…”
Get full text

Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects by BROWN, Rebecca N. K. L, MOHSEN, Ali, GREEN, Darren, HOEFIELD, Richard A, SUMMERS, Lucinda K. M, MIDDLETON, Rachel J, O'DONOGHUE, Donal J, KALRA, Philip A, NEW, David I

“…Chronic kidney disease (CKD) is increasingly prevalent worldwide. Furthermore, obesity is now a global problem with major health implications. There is a clear…”
Get full text

Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms by Caplin, Ben, Nitsch, Dorothea, Gill, Herpreet, Hoefield, Richard, Blackwell, Scott, MacKenzie, Douglas, Cooper, Jackie A., Middleton, Rachel J., Talmud, Philippa J., Veitch, Peter, Norman, Jill, Wheeler, David C., Leiper, James M.

“…In patients with chronic kidney disease, high plasma levels of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, are thought to…”
Get full text

The effects of statins on the progression of atherosclerotic renovascular disease by Cheung, Ching M, Patel, Amit, Shaheen, Nilam, Cain, Sharon, Eddington, Helen, Hegarty, Janet, Middleton, Rachel J, Cowie, Alistair, Mamtora, Hari, Kalra, Philip A

“…The aim was to examine the influence of statin therapy on the natural history of atherosclerotic renal artery stenosis (RAS). Our hospital atherosclerotic…”
Get more information

Systemic lupus erythematosus, eosinophilic vasculitis and acalculous cholecystitis by Hegarty, Janet, Chiu, Diana Yuan Yng, Middleton, Rachel J., Haeney, Mansel M., Newstead, Chas G., Bruce, Ian N., Kalra, Philip A., O'Donoghue, Donal J.

“…Patients with atypical features of a common disease often pose diagnostic challenges, as they may have two distinct disease entities, a rare manifestation of…”
Get full text

FP707LONG TERM OUTCOMES OVER 2 YEARS FOLLOWING A DIALYSIS ADEQUACY QUALITY IMPROVEMENT INITIATIVE by Youssouf, Sajeda, Nache, Azri, Shnathappa, Arunkumar, Green, Perlie, Middleton, Rachel J, Shurrab, Aladdin E, O'Riordan, Edmond, Kalra, Philip A, Hegarty, Janet

Get full text

The Prevalence and Risk Factors for Anaemia in a Population with Diabetes Mellitus by Middleton, Rachel J, Foley, Robert N, McElduff, Patrick, Gibson, John M

Get full text

The Unrecognised Prevalence of Chronic Kidney Disease in Patients with Diabetes by Middleton, Rachel J, Foley, Robert N, McElduff, Patrick, Gibson, John M

Get full text